Global Allergy Diagnostics and Testing Market Growth (Status and Outlook) 2025-2031

The global Allergy Diagnostics and Testing market size is predicted to grow from US$ 1519 million in 2025 to US$ 2507 million in 2031; it is expected to grow at a CAGR of 8.7% from 2025 to 2031.

Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.

The Allergy Diagnostics Reagent market is driven by the increasing prevalence of allergic disorders and the growing demand for accurate and early diagnosis. Allergies have become a global health concern, affecting a significant portion of the population, and there is a rising awareness about the importance of identifying allergens to manage symptoms effectively. The development of advanced allergy diagnostics reagents, including allergen extracts, specific IgE tests, and molecular assays, has improved the accuracy and specificity of allergy testing, contributing to market growth. Moreover, the adoption of personalized medicine approaches and the emphasis on targeted treatments align with the need for precise allergy diagnosis to tailor therapies for individual patients. However, the market also faces challenges, including the diversity of allergens and the complexity of immune responses, making accurate diagnosis complex. Additionally, addressing regulatory approvals, standardization of testing procedures, and reimbursement issues pose obstacles for manufacturers and healthcare providers. To succeed, stakeholders must focus on continuous innovation in reagent development, expanding the range of detectable allergens, and collaborating with healthcare systems to ensure accurate and accessible allergy diagnostics for patients. Addressing challenges while providing reliable and comprehensive allergy testing solutions will drive market growth and contribute to better allergy management and patient outcomes.

LPI (LP Information)' newest research report, the “Allergy Diagnostics and Testing Industry Forecast” looks at past sales and reviews total world Allergy Diagnostics and Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Allergy Diagnostics and Testing sales for 2025 through 2031. With Allergy Diagnostics and Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Allergy Diagnostics and Testing industry.

This Insight Report provides a comprehensive analysis of the global Allergy Diagnostics and Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Allergy Diagnostics and Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Allergy Diagnostics and Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Allergy Diagnostics and Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Allergy Diagnostics and Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Allergy Diagnostics and Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Inhaled Allergens
Food Allergens
Drug Allergens
Other Allergens

Segmentation by Application:
Diagnostic Laboratories
Hospital-based Laboratories
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
BioMerieux
Minaris Medical America
PerkinElmer
HAL Allergy Group
Siemens Healthineers
Stallergenes Greer
HOB Biotech Group
Lincoln Diagnostics
MEDIWISS Analytic
Danaher
Hycor Biomedical

Please note: The report will take approximately 2 business days to prepare and deliver.